<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04039152</url>
  </required_header>
  <id_info>
    <org_study_id>AssiutUU</org_study_id>
    <nct_id>NCT04039152</nct_id>
  </id_info>
  <brief_title>Impact of Antimicrobial Stewardship Program</brief_title>
  <official_title>Impact of Antimicrobial Stewardship Program on Antibiotics Use in Neonatal Intensive Care Unit at Assiut University Children's Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Establishing an antibiotic policy based on the local culture sensitivity records to ensure
      rational use of antibiocs, then measure the clinical and economic impact of this local
      antibiotic policy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Objective

        -  The Ultimate aims of antimicrobial stewardship program are to improve antimicrobials
           efficacy, minimize their adverse effects and limit antimicrobial resistance.

        -  The aim of this study is to measure the clinical &amp; economic impact of antimicrobial
           stewardship program interventions.

      Methodology

      Study Design:

      • Prospective-audit with feedback program strategy (Single-center, prospective, pre- and
      post-intervention study).

      Setting:

      • This study will be conducted in Neonatal Intensive Care Unit of Assiut University
      Children's Hospital, Assiut University, Assiut, Egypt.

      Timing:

      • 12- 18 months.

      Ethical Approval:

      • This study approved by the University Ethics Medical Committee. Informed consent is
      unnecessary since antimicrobial stewardship program interventions represent a part of routine
      clinical practice. Patients records will be identified by coded numbers to maintain privacy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality rate in each group</measure>
    <time_frame>18 month</time_frame>
    <description>Number of deaths</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Average Length of hospital stay in each group</measure>
    <time_frame>18 month</time_frame>
    <description>In days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Antibiotics consumption</measure>
    <time_frame>18 month</time_frame>
    <description>in the form of defined daily doses</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Blood Stream Infections</condition>
  <arm_group>
    <arm_group_label>Pre- interventions group</arm_group_label>
    <description>Without clinical pharmacists recommendations to optimize antibiotics use</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post - interventions group</arm_group_label>
    <description>interventions include clinical pharmacists recommendations to optimize antibiotics use</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical pharmacists recommendations to optimize antibiotics use</intervention_name>
    <description>Optimal dosing, drug bug mismatch</description>
    <arm_group_label>Post - interventions group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Neonates taking antbiotics admitted to NICU
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients admitted to the Neonatal intensive care unit (NICU) during study period
             and administered any antibiotic were included in the study.

        Exclusion Criteria:

          -  Patients Who have no antibiotics during their length of stay
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>30 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Neveen Abdelaal</last_name>
    <phone>00201005647073</phone>
    <email>niveeneltonsy@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut University</name>
      <address>
        <city>Assiut</city>
        <zip>71511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neveen Abdelaal</last_name>
      <phone>00201005647073</phone>
      <email>niveeneltonsy@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 29, 2019</study_first_submitted>
  <study_first_submitted_qc>July 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2019</study_first_posted>
  <last_update_submitted>July 18, 2020</last_update_submitted>
  <last_update_submitted_qc>July 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Neveen Hassan</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Participant data will not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

